Jamshed Agha in Saint Louis, Missouri

Home Missouri Saint Louis

Jamshed Agha has Hematology/oncology as his primary medical specialty. Their primary office is: 10050 Kennerly Rd in Saint Louis, Missouri. There is an additional office location, for a total of two, for Jamshed Agha that can be viewed further down.

They're a part of the: Mercy Clinic Oncology Llc medical group which has around 24 members. You can call their office at 314-849-6066 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1989 (around 35 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Jamshed Gul Agha Office Phone and Directions

Jamshed Agha
Mercy Clinic Oncology Llc
10050 Kennerly Rd
Saint Louis, Missouri 63128
314-849-6066

Patient Ratings
Please rate your experience with Jamshed Agha below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 314-849-6066

Enter a starting address:

Healthcare Info for Jamshed Agha

Medical School: Sorry, his university is not listed
Graduation Year: 1989
The Primary Medical Specialty for Jamshed Agha is listed as: Hematology/oncology
Approximate Years of Experience: 35
PAC (PECOS ID)#: 0143398545
NPI #: 1720041395
NPI Created On: 04/06/2006
NPI Last Updated Listed as: 09/10/2012
Primary Taxonomy Code: 207RH0003X
License Number:
2002016138
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Celtic Insurance Company
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Punjabi, Hindi, Pakistani.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 30 minutes per day
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788604705

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788604707

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788604709

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788604713

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788604711

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790253447

Being Disputed:: No

Product Related: No

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790254141

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Rubraca

Open Associated Drug #1: 69660-201-91

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007543

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007545

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793814857

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Additional Office Locations

1. Mercy Clinic Oncology Llc
607 S New Ballas Rd
Saint Louis, MO 63141
3300 Mercy Clinic Oncology And Hematolog
Group Members: 24

Phone: 314-849-6066

Enter a starting address:

Hematology/oncology Professionals in Saint Louis

1.
Jeffrey Magee

1 Childrens Pl
Saint-louis, MO
Washington University

2.
Andrew Cluster

1 Childrens Pl
Saint-louis, MO
Washington University

3.
Minxiang Gu MD

3635 Vista Ave
Saint-louis, MO
Ssm Health Care Group

4.
Minxiang Gu MD

3655 Vista Ave
Saint-louis, MO
Ssm Health Care Group

5.
Minxiang Gu MD

3685 Vista Ave
Saint-louis, MO
Ssm Health Care Group

6.
Minxiang Gu MD

10101 Woodfield Ln
Saint-louis, MO
Ssm Health Care Group

Providers in Mercy Clinic Oncology Llc

1.Jamshed Agha

10050 Kennerly Rd
Saint Louis Mo 63128-2106
Mercy Clinic Oncology Llc
Hematology/oncology

2.Jamshed Agha

607 S New Ballas Rd
Saint Louis Mo 63141-8219
Mercy Clinic Oncology Llc
Hematology/oncology

3.Somasekhara Bandi Md

15945 Clayton Rd
Ballwin Mo 63011-2490
Mercy Clinic Oncology Llc
Hematology/oncology

4.Somasekhara Bandi Md

6435 Chippewa St
Saint Louis Mo 63109-2104
Mercy Clinic Oncology Llc
Hematology/oncology

5.Somasekhara Bandi Md

607 S New Ballas Rd
Saint Louis Mo 63141-8219
Mercy Clinic Oncology Llc
Hematology/oncology

6.Deepthi Busayavalasa

6435 Chippewa St
Saint Louis Mo 63109-2104
Mercy Clinic Oncology Llc
Hematology/oncology

View all 24 members of Mercy Clinic Oncology Llc medical group